KR790001082B1 - Process for preparing pyrido(3,4-d)pyridazines - Google Patents

Process for preparing pyrido(3,4-d)pyridazines Download PDF

Info

Publication number
KR790001082B1
KR790001082B1 KR7500536A KR750000536A KR790001082B1 KR 790001082 B1 KR790001082 B1 KR 790001082B1 KR 7500536 A KR7500536 A KR 7500536A KR 750000536 A KR750000536 A KR 750000536A KR 790001082 B1 KR790001082 B1 KR 790001082B1
Authority
KR
South Korea
Prior art keywords
reaction
acid
compound
group
pyrido
Prior art date
Application number
KR7500536A
Other languages
Korean (ko)
Inventor
쇼지로우 유루기
신따로우 기꾸찌
Original Assignee
다쓰오까 스에오
다게다 야꾸힝 고우교 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다쓰오까 스에오, 다게다 야꾸힝 고우교 가부시기가이샤 filed Critical 다쓰오까 스에오
Priority to KR7500536A priority Critical patent/KR790001082B1/en
Application granted granted Critical
Publication of KR790001082B1 publication Critical patent/KR790001082B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pyrido(3,4-d) pyridazines (I; R1 = H, Me, Et; X = halogen atom; R2 = substituted or unsubstitude cyclic amino), useful as diuretics, were prepd. by treating secondary cyclic amines with compd. (II; R3 = H, low alkyl or aralkyl) and then opening reaction of the ether group when R3 = low alkyl or aralkyl.

Description

피리도 [3,4-d]피리다진류의 제조법Manufacturing method of pyrido [3,4-d] pyridazines

본 발명은, 일반식The present invention is a general formula

Figure kpo00001
Figure kpo00001

[식중, R1은 수소원자 또는 메틸, 에틸기를, R2는 환상아미노기를 나타냄]으로 표시되는 피리도 [3, 4-d]피리다진류의 제조법에 관한 것이다.In the formula, R 1 relates to a method for producing pyrido [3,4-d] pyridazines represented by hydrogen atom or methyl, ethyl group, R 2 represents cyclic amino group.

본 발명자들은, 여러가지 검토한 결과,The present inventors have studied variously,

일반식,General Formula,

Figure kpo00002
Figure kpo00002

[식중, R1은 상기와 같은 의의를, X는 할로겐원자를, R3은 수소원자, 저급알킬 또는 아랄킬기를 나타냄.]로 표시되는 화합물과 환상아민을 반응시키며, R3이 저급알킬 또는 아랄킬기를 나타낸 경우에는 다시 에에테르기의 개열(開裂)반응에 불여서, 피리도[3, 4-d]피리다진류(I)를 제조하는 방법과, 제조된 피리다진류(I)는, 강력한 이뇨작용을 나타낼뿐만 아니라, 수용성에 뛰어난 주사제로서도 사용할 수 있다는것을 발견하고, 이들에 의거해서 본 발명을 완성하였다.Wherein R 1 represents the same meaning as described above, X represents a halogen atom, R 3 represents a hydrogen atom, a lower alkyl or an aralkyl group, and the cyclic amine is reacted, and R 3 represents a lower alkyl or In the case where the aralkyl group is shown, the pyrodo [3,4-d] pyridazines (I) and the pyridazines (I) thus prepared are further blown by the cleavage reaction of the ether group. The present invention has been completed based on these findings, as well as exhibiting a strong diuretic effect and being used as an injection excellent in water solubility.

즉, 본 발명은, 화합물(Ⅱ)과 환상아민을 반응시켜, R3이 저급알킬 또는 아랄킬기를 나타낼 경우에는, 다시 에에테르기의 개열반응에 붙이는 피리다진류(I)의 제조법에 관한 것이다.That is, this invention relates to the manufacturing method of the pyridazines (I) which, when reacting a compound (II) and a cyclic amine, and R < 3 > represents a lower alkyl or an aralkyl group, attaches again to the cleavage reaction of an ether group. .

상기 일반식(I), (Ⅱ)에 있어서 R1로 표시된 저급알킬기로서는, 메틸, 에틸이 쓰여지며, 또일반식(Ⅱ)에 있어서 X로 표시된 할로겐으로서는, 예컨대 염소, 취소, 옥소등이 쓰여진다. R2로 표시된 환상 아미노로서는, 예컨대 피페리디노, 피로리디노, 몰포리노기등의 질소원자를 1개 이상 갖는 5또는 6원환(圓環)을 나타내며 예컨대, 2-메틸몰포리노, 2, 6-디메틸몰포리노, 2, 3-디메틸몰포리노기등처럼 상기와 같은 저급알킬기를 치환기로서 갖고 있어도 좋으며, 피리 다진류(Ⅰ)에 있어서 1위와 4위의 환상 아미노기는 상호간에 달려져 있어도 좋다. R3은, 상기와 같은 저급알킬기를 나타내는 외에, 예컨대 벤질, 페네틸등의 아랄킬기를 나타낸다. 또한 OH기는 7위의 페닐기의 4위에 치환하고 있음을 나타낸다.As the lower alkyl group represented by R 1 in the general formulas (I) and (II), methyl and ethyl are used. As the halogen represented by X in the general formula (II), for example, chlorine, cancellation, oxo and the like are used. . As the cyclic amino represented by R 2 , for example, 5- or 6-membered ring having one or more nitrogen atoms such as piperidino, pyrrolidino, and morpholino group is represented. For example, 2-methylmorpholino, 2, 6 The lower alkyl group as described above may be substituted as a substituent, such as -dimethyl morpholino, 2, 3-dimethyl morpholino group, or the like. The cyclic amino groups in the 1st and 4th positions in the pyridazines (I) may be mutually dependent. R < 3 > represents aralkyl groups, such as benzyl and phenethyl, besides showing the lower alkyl group as mentioned above. In addition, an OH group is substituted in the 4th position of the phenyl group of a 7th position.

본 발명 방법에 있어서의 원료화합물(Ⅱ)은 일반식The raw material compound (II) in the method of the present invention is a general formula

Figure kpo00003
Figure kpo00003

[식중, R1및 R3은 전기와 동의의]로 표시되는 화합물(Ⅲ)을 할로겐화해서 얻어진다. 이 할로겐화 반응은, 용매의 존재하 또는 부 존재하에 일반식(Ⅲ)의 화합물에 할로 겐화제를 작용시킴으로써 행하여 진다. 본 공정의 할로겐화에 쓰여지는 할로겐화제로서는, 일반식(Ⅲ)의 화합물의 1, 4 위의 옥소기를 할로겐원자로 치환해서 얻는 것이라면 여하한 것이라도 좋으며, 예컨대 5염화인, 5취화인 등의 5할로겐화인, 옥시염화인, 옥시취화인 등의 옥시할로겐화인, 티오닐클로리드, 티오닐보토마이드, 티오닐아이오다이드 등의 티오닐할라이드 또는 이들의 적당한 혼합물등이 쓰여진다. 이들의 할로겐화제의 사용량은, 일반식(Ⅲ)의 화합물 1몰에 대해서 통상적으로 약 5-20몰 정도이고. 본 공정에 있어서 반응용매를 쓸 경우, 그 용매로서는, 예컨대 벤젠, 톨루엔, 헥산 등의 탄화수소류, 디에틸에에테르, 테트라히드로푸란등의 에에테르류, 클로로포름, 디클로로에탄 등의 할로겐화탄화, 탄화수소류등의 본 반응을 저해하지 않는 용매가 쓰여진다. 또, 반응될 무렵에 생성되는 할로겐화수소를 제거하기 위해 적당한 염기성물질(예, 피리딘, 트리메틸아민, 트리에틸아민, N, N-디메틸아닐린등의 제3급 아민류, 초산나트륨등의 저급지방산의 알칼리금속등)을 탈산제로서 반응계에 공존시켜도 좋다. 반응온도는 특별히 제한은 없으나, 통상적인 실온 내지 약 130℃정도로 반응을 행하는 것이 실용상 바람직하다. 반응시간은 통상 약 2-5시간 정도이다. 얻어지는 화합물(Ⅱ)은, 공지된 방법 에컨대 용매추출, 액성변환, 전용(轉溶), 농축, 감압농축, 증류, 결정, 재결정, 크로마토그래피등에 의해 단리(單離)정제할수도 있지만, 통상 분리함이 없이 다음의 반응의 원료로 쓰여진다.In the formula, R 1 and R 3 are obtained by halogenating the compound (III) represented by the above. This halogenation reaction is performed by making a halogenating agent act on the compound of General formula (III) in presence or absence of a solvent. As the halogenating agent used for the halogenation of this step, any one may be obtained as long as it is obtained by substituting a halogen atom for the oxo groups of the compounds of the general formula (III), and for example, halogenated pentachloride such as phosphorus pentachloride or pentaphosphate. Phosphorus oxyhalogenated phosphorus, such as phosphorus, phosphorus oxychloride, and oxy embrittlement phosphorus, thionyl halides, such as thionyl chloride, thionyl botomide, thionyl iodide, or a suitable mixture thereof, etc. are used. The usage-amount of these halogenating agents is about 5-20 mol normally with respect to 1 mol of compounds of General formula (III). When the reaction solvent is used in this step, as the solvent, for example, hydrocarbons such as benzene, toluene and hexane, ethers such as diethyl ether and tetrahydrofuran, halogenated carbonization such as chloroform and dichloroethane and hydrocarbons The solvent which does not inhibit this reaction, such as these, is used. In addition, alkalis of lower fatty acids such as tertiary amines such as pyridine, trimethylamine, triethylamine, N, N-dimethylaniline, sodium acetate, and the like are suitable for removing hydrogen halide generated at the time of reaction. Metal, etc.) may coexist in the reaction system as a deoxidizer. There is no restriction | limiting in particular in reaction temperature, It is preferable practically to carry out reaction at normal room temperature to about 130 degreeC. The reaction time is usually about 2-5 hours. The obtained compound (II) can be isolated and purified by a known method such as solvent extraction, liquid conversion, conversion, concentration, reduced pressure concentration, distillation, crystallization, recrystallization, chromatography, and the like. It is used as raw material for the next reaction without separation.

피리도 [3, 4-d]피리다진류(I)는, 이와같이 해서 얻어진 화합물(Ⅱ)과 환상아민을 반응시킴으로써 제조할 수 있다. 이 반응은, 용매없이도 진행되지만, 적당한 용매를 씀으로써 보다 원활하게 반응을 진행시킬수도 있다. 본 반응에 쓰여지는 용매로서는, 예컨대 메틸알콜, 에틸알콜등의 알콜등의 알콜류, 테트라히드로푸란, 에틸에에테르등의 에에테르류, 벤젠, 클로로포름등의 탄화수소 또는 할로겐화탄화 수소류 또는 초산에틸 등의 에스테류등이 쓰여진다. 환상아민의 사용량은, 일반식(Ⅱ)의 화합물 1몰에 대해서 통상 2몰에서 4몰쯤이 반응용매, 탈산제를 겸해서 쓰여진다. 반응온도, 반응시간등의 반응조건도 특별히 한정되는 것은 아니다. 즉, 본 반응은 실온에서도 진행하지만 예컨대 사용용매 또는 환상아민의 비점까지의 온도로 가열해서 반응을 촉진촉진시켜도 좋다. 반응시간은, 원료화합물, 사용용매등의 종류에 의해서 달라지지지만, 통상 1-5시간정도이다. 이리하여 생성되는 일반식(1)로 표시되는 목적화합물은, 예컨대 적당한 용매(몰, 초산에틸, 벤젠, 클로로포름, 에틸알콜)로서의 추출, 재결정, 컬럼크로마토그래피등 통상적인 처리수단으로 단리, 정제할 수 있다.Pyrido [3, 4-d] pyridazines (I) can be manufactured by making compound (II) obtained in this way and cyclic amine react. The reaction proceeds without a solvent, but the reaction can be carried out more smoothly by using a suitable solvent. Examples of the solvent used in the reaction include alcohols such as alcohols such as methyl alcohol and ethyl alcohol, ethers such as tetrahydrofuran and ethyl ether, hydrocarbons such as benzene and chloroform, halogenated hydrocarbons, and ethyl acetate. Esters are used. As for the usage-amount of a cyclic amine, about 2 mol-about 4 mol are normally used as a reaction solvent and a deoxidizer with respect to 1 mol of compounds of General formula (II). The reaction conditions such as reaction temperature and reaction time are not particularly limited. In other words, the reaction proceeds even at room temperature, but may be accelerated by heating to a temperature up to the boiling point of the solvent or cyclic amine, for example. The reaction time varies depending on the type of raw material compound, solvent used, etc., but is usually about 1-5 hours. The target compound represented by the general formula (1) thus produced can be isolated and purified by conventional processing means such as extraction with a suitable solvent (mole, ethyl acetate, benzene, chloroform, ethyl alcohol), recrystallization, column chromatography, and the like. Can be.

또한 본 발명 방법에 있어서는, R3이 저급알킬 또는 아랄킬기를 나타낸 경우에는 상기의 방법으로 얻어지는 일반식Moreover, in the method of this invention, when R <3> represents lower alkyl or an aralkyl group, General formula obtained by said method.

Figure kpo00004
Figure kpo00004

[식중, R1및 R2는 상기와 같은 의의를, R4는 저급알킬 또는 아랄킬기를 나타냄]로 표시되는 화합물(Ⅳ)을 에에테르기의 개열(開裂)반응에 붙인다.The compound (IV) represented by [wherein R 1 and R 2 have the same meaning as described above and R 4 represents a lower alkyl or an aralkyl group] is added to the cleavage reaction of the ether group.

에에테르기의 개열반응에 쓰여지는 방법은, 7위 페닐기의 치환기 R4O를 개열해서 수산기로 유도할 수 있는 방법이라면 좋고, 예컨대 가수 분해 또는 환원등이 번용(繁用)된다. 가수분해의 방법을 쓸 경우는, 화합물(Ⅳ)을 물 또는 유기용매중 적당한 촉매의 존재하에 가수분해를 행하는 것이 좋다. 촉매로서는, 통상 예컨대 염산, 취화수소산, 옥화수소산등의 무기산, 트리프루오로초산, 톨루엔술폰산 등의 유기산, 염화알루미늄, 3염화붕소, 3등의 이른바 루이스산등이 쓰여진다. 유기용매로서는, 반응을 방해하지 않는 한 여하한 것이라도 좋으나, 액체의 촉매를 쓸 경우에는 대과잉(大過剩)의 촉매를 용매로서 사용할 수도 있다. 반응온도는, 실온으서도 충분히 반응하지만, 반응속도 조절의 목적으로 촉매의 성질에 응해서 적당히 가온 또는 냉각할수도 있다. 통상 -70-+130℃의 범위에서 행하여진다. 환원에 의한 방법으로서는 (Ⅳ)를 물 또는 유기용매중에서 환원함으로써 행할 수가 있다. 특히 R3이 아랄킬기인 경우 특히 유리하게 실시된다. 환원방법으로서는 목적을 달성하는 한여하한 방법으로도 좋지만, 특히 파라듐, 백금, 라니-니켈등의 금속 또는 이들과 탄소, 탄산, 바륨, 탄산칼슘, 규조토등의 담체(擔體)와의 혼합물물등을 촉매로 하는 수소와의 접촉환원에 의한 방법이 유리하다. 반응온도는, 통상적인 실온으로 충분하지만, 경우에 따라서는 냉각 또는 가온해서 행하여지며, 0-100℃의 범위가 바람직하다. 수소의 압력은 상압(常壓)으로 충분하지만, 1-150kg/㎠정도의 범위에서 가압하는 것에 의해서도 행하여 진다. 이리하여 얻어지는 목적화합물(I)은, 상기와 같은 통상적인 처리수단으로 단리, 정제할 수가 있다. 또 목적화합(I)은, 일반식The method used for the cleavage reaction of the ether group may be any method capable of cleaving the substituent R 4 O of the 7th-phenyl group and leading to a hydroxyl group. For example, hydrolysis or reduction is commonly used. When using the method of hydrolysis, it is preferable to hydrolyze compound (IV) in the presence of a suitable catalyst in water or an organic solvent. As the catalyst, for example, inorganic acids such as hydrochloric acid, hydrobromic acid and hydrofluoric acid, organic acids such as trifluoroacetic acid and toluenesulfonic acid, and so-called Lewis acids such as aluminum chloride, boron trichloride, and the like are used. The organic solvent may be any one so long as it does not interfere with the reaction. However, when a liquid catalyst is used, a large excess of catalyst may be used as the solvent. Although the reaction temperature sufficiently reacts even at room temperature, it may be appropriately heated or cooled depending on the nature of the catalyst for the purpose of controlling the reaction rate. Usually, it is performed in the range of -70- + 130 ° C. As a method of reduction, it can carry out by reducing (IV) in water or an organic solvent. It is especially advantageous when R 3 is an aralkyl group. As the reduction method, any method for achieving the purpose may be used, but a mixture of metals such as palladium, platinum and Raney-nickel or carriers such as carbon, carbonate, barium, calcium carbonate and diatomaceous earth, etc. The method by catalytic reduction with hydrogen which uses as a catalyst is advantageous. Although reaction temperature is sufficient as normal room temperature, it is carried out by cooling or warming depending on a case, and the range of 0-100 degreeC is preferable. Although the pressure of hydrogen is sufficient as normal pressure, it is also performed by pressurizing in the range of about 1-150 kg / cm <2>. The target compound (I) thus obtained can be isolated and purified by the conventional treatment means as described above. The objective compound (I) is a general formula

Figure kpo00005
Figure kpo00005

[식중, R1은 상기와 같은 의의를, R5는 저급알킬, 아랄킬 또는 아릴기를, n은 0, 1 또는 2를 나타냄]로 표시되는 화합물과 상술한 바와같은 환상아민을 반응시키든지, 또는 일반식Wherein R 1 represents the same meaning as described above, R 5 represents a lower alkyl, aralkyl or aryl group, n represents 0, 1 or 2, or the cyclic amine as described above Or general formula

Figure kpo00006
Figure kpo00006

[식중, R1및 R2는 상기와 같은 의의를, R6는 아랄킬 또는 알킬기를 나타냄]로 표시되는 화합물에, 예컨대 과망간산, 크롬산, 질산, 과산화수소, 산소산, 금속착염, 금속염류, 공기, 오존, 니트로벤젠, 또는 그 관련 화합물등의 산화제를 작용시키는 등에 의해서 제조할 수가 있다.Wherein R 1 and R 2 represent the same meaning as described above, and R 6 represents an aralkyl or alkyl group. For example, permanganic acid, chromic acid, nitric acid, hydrogen peroxide, oxygen acid, metal complex salt, metal salt, air, It can manufacture by acting an oxidizing agent, such as ozone, nitrobenzene, or its related compound.

이리해서 얻어지는 목적화합물(I)은, 7위 페놀성 수산기를 유리된 체로 사용해도 좋으나, 예컨대 나트륨, 칼륨등의 무독성 양이온과의 염을 형성시켜서 써도 좋다. 또, 화합물(I)은, 수산, 푸마르산, 주석산, 능금산, 트리푸오로초산등의 유기산, 염산, 황산, 질산, 인산등의 무기산과의 염을 형성하는 일도 있다 또, 본 발명 방법의 원료화합물도 이들의 산염으로서 사용할 수가 있다.The target compound (I) thus obtained may be used as a free sieve with the seventh-position phenolic hydroxyl group, but may be used by forming a salt with a non-toxic cation such as sodium or potassium. The compound (I) may also form salts with organic acids such as hydroxyl, fumaric acid, tartaric acid, nitric acid, and trifuroacetic acid, and inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid and phosphoric acid. It can also be used as these acid salts.

또한, 상기 화합물(Ⅲ)은, 예컨대 아래식에서 나타내는 것 처럼해서 제조할 수가 있다. 즉, 화합물(Ⅴ)와 N-치환 마레인이미드를 디일스 알더형 부가반응을 행해서 화합물(Ⅵ)로 하고, 이어서 산 또는 염기로 처리하여 화합물(Ⅵ)로 한후, 히드라진과 반응시킴으로써 화합물(Ⅲ)을 제조할 수 있다.In addition, the said compound (III) can be manufactured as shown, for example by following formula. That is, compound (V) and N-substituted maleinimide are subjected to diyl alder type addition reaction to compound (VI), followed by treatment with acid or base to form compound (VI), followed by reaction with hydrazine to give compound ( III) can be prepared.

Figure kpo00007
Figure kpo00007

[식중, R은 지방족기 또는 방향족기를, R1은 상기와 같은 의의를 나타냄][Wherein R represents an aliphatic group or an aromatic group and R 1 represents the same significance as above]

또, 화합물(Ⅴ)의 대신에 화합물(Ⅷ)을 원료로 사용하여, 상기의 경우와 같이 해서 제조할 수도 있다. 이를 나타내자면 다음과 같은 것이다.In addition, the compound (V) may be used as a raw material instead of the compound (V), and may be produced in the same manner as in the above case. This is shown below.

Figure kpo00008
Figure kpo00008

Figure kpo00009
Figure kpo00009

[식종, R, R1, R2, R3및 X는 상기와 같은 의의][Equation, R, R 1 , R 2 , R 3 and X are the same as above]

또는, 다음식에서 나타내는 바와같이, 화합물(XⅢ)과 시아노티오아세트아미드에서 얻어지는 화합물(XV)를 탈황해서 화합물(XV)로 하고, 이어서 가수분해하여(XⅥ)을 얻고, 이 (XⅥ)을 탈수, 폐환(閉環)해서 화합물(XⅦ)로 하고, 이것에 히드라진을 반응시키면 화합물(XI)이 얻어지며, 이것에 의해 상기와 같이 해서(Ⅲ)을 제조할 수가 있다.Alternatively, as shown in the following formula, compound (XV) obtained from compound (XIII) and cyanothioacetamide is desulfurized to give compound (XV), which is then hydrolyzed to obtain (XVI), which dehydrates (XVI). And ring-closing to form compound (X ') and reacting hydrazine with it yield compound (XI), whereby (III) can be produced as described above.

Figure kpo00010
Figure kpo00010

Figure kpo00011
Figure kpo00011

[식중, R1및 R3은 상기와 같은 의의를, R7은 저급 알킬기를 나타냄][Wherein R 1 and R 3 are as defined above and R 7 represents a lower alkyl group]

이와같이해서 얻어지는 본 발명의 목적화합물(I)은, 뛰어난 이뇨작용을 가지며, 이뇨제등의 의약으로서 유용하며, 게다가 이들 화합물은 염기성 영역에 있어서 수용성이며, 제재(製劑)상에 있어서도 뛰어난 특징을 갖는다. 의약으로서 쓸 경우, 정제, 캡셀제, 산제, 과립제등으로서 경구적으로 사용하는 외에, 주사제로서 비경구적으로 투여할 수도 있다. 투여량은 성인 1일량으로서, 경구투여 경우 약 10-200mg, 비경구적투여의 경우 약 5-100mg정도이다.The target compound (I) of the present invention thus obtained has excellent diuretic action, is useful as a medicament such as a diuretic agent, and these compounds are also water-soluble in the basic region and have excellent characteristics in preparation. When used as a medicament, in addition to oral use as tablets, capsules, powders, granules and the like, it may be administered parenterally as an injection. The daily dose is about 10-200 mg for oral administration and about 5-100 mg for parenteral administration.

다음에 본 발명의 참고예, 실시예를 든다.Next, reference examples and examples of the present invention are given.

[참고예 1]Reference Example 1

4-히드록시 페니실부로미드 35g, 포름아미드 150ml 및 빙초산 120ml의 혼합물을 120-130℃에 6.5시간 가열하고, 감압하에 초산을 유거(留去)하고, 잔류물을 300ml의 빙수에 부어, 초산에틸로서 4회 추출한다. 추출액을 무수황산나트륨으로 건조시킨후, 초산에틸을 유거하면 4-(4-히드록시페닐)옥사졸이 얻어진다. 본품에 N-페닐마레인 이미드 30g을 섞어, 유욕상(油浴上) 120-130℃로 4시간 가열하고, 냉각후 에타놀을 가해서, 결정을 여취하면, 2-(4-히드록시페닐)-N-페닐피리딘-4. 5-디카르복시이미드 25g이 얻어진다. 융점 250-260℃A mixture of 35 g of 4-hydroxy penicylburomide, 150 ml of formamide and 120 ml of glacial acetic acid was heated at 120-130 ° C. for 6.5 hours, acetic acid was distilled off under reduced pressure, and the residue was poured into 300 ml of ice water to give acetic acid. Extract four times as ethyl. After drying the extract with anhydrous sodium sulfate, ethyl acetate is distilled off to give 4- (4-hydroxyphenyl) oxazole. This product is mixed with 30 g of N-phenylmarine imide, heated to an oil bath phase at 120-130 ° C. for 4 hours, ethanol is added after cooling, and crystals are filtered to give 2- (4-hydroxyphenyl). -N-phenylpyridine-4. 25 g of 5-dicarboxyimide are obtained. Melting point 250-260 ℃

(분 해)(Dissolve)

원소분석 C19H12O3N2로 하여Elemental Analysis C 19 H 12 O 3 N 2

계산치 C 72.14, H 3.82, N 8.86Calculated C 72.14, H 3.82, N 8.86

실측치 C 71.82, H 3.71, N 8.40Found C 71.82, H 3.71, N 8.40

[참고예 2]Reference Example 2

2-(4-히드록시페닐)-N-페닐피리딘-4. 5-디카르복시이미드 4g, 빙초산 30ml, 포수(抱水)히드라딘 4g의 혼합물을 1시간 자불(煮沸)환류시켜, 냉각후 석출된 결점을 여취(濾取)하면 7-(4-히드록시페닐)-1, 2, 3, 4-테트라히드로피리도 [3, 4-d]피리다딘-1, 4-디온 3.2g이 얻어진다. 융점 300℃이상2- (4-hydroxyphenyl) -N-phenylpyridine-4. A mixture of 4 g of 5-dicarboxyimide, 30 ml of glacial acetic acid, and 4 g of catcher hydradine was refluxed for 1 hour, and the precipitates precipitated after cooling were filtered to 7- (4-hydroxyphenyl). 3.2 g of) -1, 2, 3, 4-tetrahydropyrido [3, 4-d] pyridinedine-1, 4-dione are obtained. Melting point over 300 ℃

원소분석 C13H9O3N3로 하여Elemental Analysis by C 13 H 9 O 3 N 3

계산치 C 61.17, H 3.55, N 16.47Calculated C 61.17, H 3.55, N 16.47

실측치 C 60.48, H 3.29, N 16.27Found C 60.48, H 3.29, N 16.27

[참고예 3]Reference Example 3

(4-벤닐옥시)벤조일피루빈산에틸 16g, 시아노리오아세트 아미드 6.7g, 트리에틸아민 1ml과 에타놀 50ml의 혼합물을 수용상에서 2시간 환류시킨다. 냉각후 석출된 적색결점을 여취하고, 에타놀로 세정하면 융점 155-160℃의 6-(4-벤질옥시페닐)-3-시아노-4-에톡시카르보닐-2[1H]-티오피리돈이 14g얻어진다.A mixture of 16 g of ethyl 4- (4-benyloxy) benzoylpyruvate, 6.7 g of cyanorioacetamide, 1 ml of triethylamine and 50 ml of ethanol was refluxed in the aqueous phase for 2 hours. After cooling, the precipitated red defect was filtered off, and washed with ethanol to give 6- (4-benzyloxyphenyl) -3-cyano-4-ethoxycarbonyl-2 [1H] -thiopyridone at a melting point of 155-160 ° C. This 14 g is obtained.

원소분석 C22H18O3N2S로 하여Elemental Analysis C 22 H 18 O 3 N 2 S

이론값 C 67.67, H 4.65, N 7.18Theoretical C 67.67, H 4.65, N 7.18

실험값 C 67.44, H 4.53, N 7.17Experimental values C 67.44, H 4.53, N 7.17

[참고예 4]Reference Example 4

6-(4-벤질옥시페닐)-3-시아노-4-에톡시칼보닐-2[1H]-티오피리돈 60g과 라니니켈 1.2kg의 아세톤 1.2ℓ혼합물을 환류하에서 1시간 저어 섞은 후, 라니니켈을 여별(濾別)하고, 여액을 농축하여, 잔류물을 실리카겔 컬럼크로마토 그래피로 분리 정제하면, 융점 135-137℃의 무색 침상정(針狀晶)의 6-(4-벤질옥시페닐)-3-시아노-4-에톡시카르브닐 피리딘이 16g 얻어진다.After stirring 60 g of 6- (4-benzyloxyphenyl) -3-cyano-4-ethoxycarbonyl-2 [1H] -thiopyridone and 1.2 kg of acetone 1.2 liters under reflux for 1 hour, The Ranikel was filtered off, the filtrate was concentrated, and the residue was separated and purified by silica gel column chromatography. The colorless needles of 6- (4-benzyloxyphenyl) having a melting point of 135-137 占 폚 are obtained. 16 g of) -3-cyano-4-ethoxycarbyl pyridine is obtained.

원소분석 C22H18O3N2로 하여Elemental Analysis C 22 H 18 O 3 N 2

이론값 C 73.73, H 5.06, N 7.82Theoretical C 73.73, H 5.06, N 7.82

실험값 C 73.81, H 5.01, N 7.63Experimental value C 73.81, H 5.01, N 7.63

[참고예 5]Reference Example 5

6-(4-벤질옥시페닐)-3-시아노-4-에톡시 카르보닐 피리딘 9g과 10% 수산화나트륨 수용액 180ml을 봉관중(封管中)에서 3시간 150-160로 가열하고, 반응물을 농축하여, 농염산으로 산성으로 하여 석출하는 결정을 여취, 건조후 초산에서 재결정하면 융점 253-255℃의 담황색 인편정(鱗片晶)의 6-(4-벤질옥시페닐)신코메론산이 8.7g이 얻어진다.9 g of 6- (4-benzyloxyphenyl) -3-cyano-4-ethoxy carbonyl pyridine and 180 ml of 10% aqueous sodium hydroxide solution were heated to 150-160 for 3 hours in a sealed tube, and the reaction was carried out. Concentrate, acidify with concentrated hydrochloric acid, and precipitate the crystals. After drying, recrystallization from acetic acid, 8.7 g of 6- (4-benzyloxyphenyl) cincomeronic acid with a pale yellow phosphorus crystal having a melting point of 253-255 ° C Obtained.

원소분석 C20H14O5N로 하여Elemental Analysis C 20 H 14 O 5 N

이론값 C 68.76, H 4.33, N 4.01Theoretical C 68.76, H 4.33, N 4.01

실험값 C 68.30, H 4.29, N 3.84Experimental value C 68.30, H 4.29, N 3.84

[참고예 6]Reference Example 6

6-(4-벤질옥시페닐)신코메론산 8.0g과 무수초산 160ml을 1시간 환류, 온시(溫時)불용물을 여별하고, 여액을 냉각하면 융점 216-218℃의 황색결정으로서 6-(4-벤질옥시페닐)신코메론산 무수물 4.7g이 얻어진다.8.0 g of 6- (4-benzyloxyphenyl) shincomeronic acid and 160 ml of acetic anhydride were refluxed for 1 hour, and the insoluble matters were separated on time, and the filtrate was cooled. As a yellow crystal having a melting point of 216-218 ° C, 6- ( 4.7 g of 4-benzyloxyphenyl) cincomeronic anhydride are obtained.

원소분석 C20H12O4N로 하여Elemental Analysis C 20 H 12 O 4 N

이론값 C 72.50, H 3.96, N 4.23Theoretical C 72.50, H 3.96, N 4.23

실험값 C 72.75, H 3.94, N 3.99Experimental value C 72.75, H 3.94, N 3.99

[참고예 7]Reference Example 7

6-(4-벤질옥시페닐)신코메론산 무수물 6.5g과 포수 히드라진 13ml의 초산 65ml용액을 2시간 환류하에서 저어 섞는다. 냉후 반응물에 물을 가하여 석출하는 결정을 여취하고, 수세후 건조하면 융점 300℃이상의 무색결정으로서 7-(4-벤질옥시페닐)-1, 4-디옥소-1, 2, 3, 4-테트라히드로피리도 [3, 4-d]피리다진이 6.0g 얻어진다.6.5 g of 6- (4-benzyloxyphenyl) cincomeric anhydride and 65 ml of 13 ml of catcher hydrazine are added under stirring at reflux for 2 hours. After cooling, the precipitates are filtered by adding water to the reactants, and when washed and dried, they are colorless crystals having a melting point of 300 ° C. or higher, 7- (4-benzyloxyphenyl) -1, 4-dioxo-1, 2, 3, 4-tetra 6.0 g of hydropyrido [3,4-d] pyridazines are obtained.

원소분석 C20H15O3N3로 하여Elemental Analysis C 20 H 15 O 3 N 3

이론값 C 69.55, H 4.38, N 12.17Theoretical C 69.55, H 4.38, N 12.17

실험값 C 69.27, H 4.16, N 11.83Experimental value C 69.27, H 4.16, N 11.83

[참고예 8]Reference Example 8

7-(4-벤질옥시페닐)-1, 4-디옥소-1, 2, 3, 4-테트라히드로피리도 [3, 4-d]피리다진 10g, 옥시염화인 100ml과 α-피코린 10ml의 혼합물을 저어 섞으면서 100-110℃에서 3시간 반응시킨다. 감압하에서 반응물을 농축하고, 잔류물에 빙수를 가하여 분해 후, 석출 결정을 여취, 수세, 건조후, 얻어진 7-(4-벤질옥시페닐)-1, 4-디클로로피리도 [3, 4-d]피리다진과 몰포린 50ml을 환류하에서 4시간 반응시킨다. 감압하에서 반응물을 농축하고, 잔류물에 물을 가하여 석출하는 결정을 여취, 수세, 건조후, 초산에틸-에타놀의 혼합용매로 부터 재결정하면 융점 206-208℃의 황색결정의 7-(4-벤질옥시페닐)-1, 4-디몰포리노피리도 [3, 4-d]피리다진이 8.5g 얻어진다.10 g of 7- (4-benzyloxyphenyl) -1, 4-dioxo-1, 2, 3, 4-tetrahydropyrido [3, 4-d] pyridazine, 100 ml of phosphorus oxychloride and 10 ml of α-phycoline The mixture is stirred for 3 hours at 100-110 ° C while stirring. The reaction product was concentrated under reduced pressure, and ice-water was added to the residue to decompose the residue, and the precipitated crystals were filtered off, washed with water, dried and then obtained 7- (4-benzyloxyphenyl) -1,4-dichloropyrido [3, 4-d ] Pyridazine and 50 ml of morpholine are reacted under reflux for 4 hours. The reaction product was concentrated under reduced pressure, and the precipitated crystal was added by adding water to the residue. The crystals were filtered off, washed with water and dried and then recrystallized from a mixed solvent of ethyl acetate-ethanol to give 7- (4-benzyl) as a yellow crystal having a melting point of 206-208 占 폚. 8.5 g of oxyphenyl) -1 and 4-dimorpholinopyrido [3,4-d] pyridazine are obtained.

원소분석 C28H29O3N5로 하여Elemental Analysis C 28 H 29 O 3 N 5

이론값 C 69.54, H 6.05, N 14..48Theoretical C 69.54, H 6.05, N 14..48

실험값 C 69.54, H 6.09, N 13.94Experimental values C 69.54, H 6.09, N 13.94

[실시예 1]Example 1

(1) 7-(4-히드록시페닐)-1, 2, 3, 4-테트라히드로피리도 [3, 4-d]피리다진-1, 4-디온 0.5g을 α-피코린 0.5ml, 옥시염화인 5ml과 함께 90-100℃에서 3시간 가열하고, 감압농축하여 잔류물에 물 10ml을 가해서 석출하는 1, 4-디클로로-7-(4-히드록시페닐)피리도[3, 4-d]피리다진 0.4g을 여취한다. 부품은 조제(粗製)인 채로 다음의 반응에 사용한다.(1) 0.5 g of 7- (4-hydroxyphenyl) -1, 2, 3, 4-tetrahydropyrido [3, 4-d] pyridazine-1, 4-dione, 0.5 ml of α-phycoline, 1,4-dichloro-7- (4-hydroxyphenyl) pyrido [3,4-] which is heated with 5 ml of phosphorus oxychloride at 90-100 ° C. for 3 hours, concentrated under reduced pressure, and precipitated by adding 10 ml of water to the residue. d] 0.4 g of pyridazine is filtered out. The parts are used in the following reactions while being prepared.

(2) (1)에서 얻어진 1, 4-디클로-7-(4-로히드록시페닐)피리도[3, 4-d]피리다진 0.4g에 몰포린 10g을 가하여 4시간, 130℃로 가열한다. 몰포린을 유거한 후, 잔류물에 물 10ml을 가하여 불용물(不溶物)을 여취하고, 이를 실리카겔 컬럼크로마토그래피(전개액(展開液), 벤젠 : 아세톤=4 : 1)로 정제하면 7-(4-히드록시페닐)-1, 4-디몰포리노피리도[3, 4-d]피리다진 0.1g이 얻어진다. 융점 285-287℃(2) 10 g of morpholine was added to 0.4 g of 1,4-dichloro-7- (4-rohydroxyphenyl) pyrido [3,4-d] pyridazine obtained in (1), and the mixture was heated to 130 ° C for 4 hours. Heat. After morpholine was distilled off, 10 ml of water was added to the residue, and the insolubles were filtered off. The residue was purified by silica gel column chromatography (expanded liquid, benzene: acetone = 4: 1) to obtain 7- 0.1 g of (4-hydroxyphenyl) -1,4-dimorpholinopyrido [3,4-d] pyridazine is obtained. Melting Point 285-287 ℃

원소분석 C21H23O3N5로 하여Elemental Analysis C 21 H 23 O 3 N 5

계산값 C 64.11, H 5.89, N 17.80Calculated Value C 64.11, H 5.89, N 17.80

실측값 C 63.97, H 5.84, N 17.90Found C 63.97, H 5.84, N 17.90

[실시예 2]Example 2

7-(4-벤질옥시페닐)-1, 4-디몰포리노피리도 [3, 4-d]피리다진 7.0g의 트리푸루오로 초산 70ml용액을 0.5시간 환류하에서 저어 섞는다. 감압하에 반응물을 농축하고, 잔류물에 벤젠 50ml을 가해서 농축한다. 잔류물을 메타놀 20ml에 녹여, 포화탄산수소 나트륨 수용액을 가하면 황색 결정이 석출한다. 이를 여취하고, 수세, 건조후 초산에틸-메타놀의 혼합액에서 재결정하면 융점 285-287℃의 담황색 침상정으로서 7-(4-히드록시페닐)-1, 4-디몰포리노피리도 [3, 4-d]피리다진 4.7g이 얻어진다.7 g of 7- (4-benzyloxyphenyl) -1,4-dimorpholinopyrido [3,4-d] pyridazine 7.0 g of tripurouaceous acid 70 ml solution was stirred under reflux for 0.5 hour. The reaction is concentrated under reduced pressure and 50 ml of benzene is added to the residue. The residue is dissolved in 20 ml of methanol, and saturated aqueous sodium hydrogen carbonate is added to precipitate yellow crystals. This was filtered off, washed with water and dried and recrystallized from a mixture of ethyl acetate-methanol. As a pale yellow needle with a melting point of 285-287 ° C, 7- (4-hydroxyphenyl) -1 and 4-dimorpholinopyrido [3, 4] -d] 4.7 g of pyridazine are obtained.

원소분석 C21H23O3N5로 하여Elemental Analysis C 21 H 23 O 3 N 5

이론값 C 64.11, H 5.89, N 17.80Theoretical C 64.11, H 5.89, N 17.80

실험값 C 63.98, H 5.74, N 17.94Experimental values C 63.98, H 5.74, N 17.94

[실시예 3]Example 3

7-(4-벤질옥시페닐)-1, 4-디몰포리노피리도 [3, 4-d]피리다진 1g을 에타놀 20ml에 용해하고, 파라듐 탄소(10%) 0.1g을 가하여 실온에서 5시간 수소기류중에서 교반한다. 촉매를 여거(濾去)하고 용액을 농축하여, 잔류물을 초산에틸-메타놀 혼액으로부터 재결정하면 7-(4-히드록시 페닐)-1, 4-디몰포리노피리도 [3, 4-d]피리다진 0.5g이 얻어진다. 융점 285-287℃1 g of 7- (4-benzyloxyphenyl) -1 and 4-dimorpholinopyrido [3,4-d] pyridazine was dissolved in 20 ml of ethanol, 0.1 g of palladium carbon (10%) was added, and 5 at room temperature. Stir in hydrogen stream. The catalyst was filtered off, the solution was concentrated, and the residue was recrystallized from ethyl acetate-methanol mixture to obtain 7- (4-hydroxyphenyl) -1,4-dimorpholinopyrido [3, 4-d]. 0.5 g of pyridazine is obtained. Melting Point 285-287 ℃

실시예 1의 방법으로 얻어진 표품(標品)과 혼용하면 융점강하를 나타내지 않는다.Melting | fusing point drop does not show when it mixes with the brand goods obtained by the method of Example 1.

[실시예 4]Example 4

7-(4-메톡시페닐)-1, 4-디몰포리노 피리도[3, 4-d]피리다진 1g을 염화메틸렌 10ml에 용해하고, -40℃로 냉각하여 3취화붕소 1g을 염화메틸렌중 1몰 용액으로 한 것을 저어 섞으면서 서서히 침가한다. 5시간 후 감압하에 용매를 류거하고, 잔류물을 에타놀과 함께 환류하에서 1시간 가열하고, 반응용액을 류거하며, 잔류물을 초산 에틸-메타놀의 혼액에서 재결정하면 7-(4-히드록시 페닐)-1, 4-디몰포리노 피리도[3, 4-d]피리다진 0.5g이 얻어진다. 융점 285-287℃실시예 1로 얻어진 표품과 혼융하여 융점 강하를 나타내지 않는다.1 g of 7- (4-methoxyphenyl) -1,4-dimorpholino pyrido [3,4-d] pyridazine was dissolved in 10 ml of methylene chloride, cooled to -40 ° C, and 1 g of boron trichloride was methylene chloride. The solution is slowly soaked while stirring with 1 molar solution. After 5 hours, the solvent was distilled off under reduced pressure, the residue was heated under reflux with ethanol for 1 hour, the reaction solution was distilled off, and the residue was recrystallized from a mixture of ethyl acetate-methanol to 7- (4-hydroxyphenyl). 0.5 g of -1,4-dimorpholino pyrido [3,4-d] pyridazine is obtained. Melting point 285-287 ° C. Melting with the standard product obtained in Example 1 does not show a melting point drop.

[실시예 5]Example 5

7-(4-이소푸로필 옥시페닐)-1, 4-디몰포리노 피리도[3, 4-d]피리다진 2g을 빙초산 20ml, 47% 취하수소산 수용액 6ml의 혼액에 가하여, 2시간 환류자불한 후, 감압하에 농축 건고하고, 잔물을 메타놀 5ml에 용해하고, 포화탄산 나트륨으로 중화한다.2 g of 7- (4-isopurophyloxyphenyl) -1 and 4-dimorpholino pyrido [3,4-d] pyridazine were added to a mixture of 20 ml of glacial acetic acid and 6 ml of 47% aqueous hydrochloric acid solution, and refluxed for 2 hours. After drying under reduced pressure, the residue is dissolved in 5 ml of methanol and neutralized with saturated sodium carbonate.

물 20ml을 가한 후 클로로포름으로 추출하고, 추출액을 류거한 잔류물을 실리카겔의 컬럼크로마토그래피(전개액, 벤젠 : 아세톤-1 : 1)로 정제하면, 7-(4-히드록시페닐)-1, 4-디몰포리노 피리도[3, 4-d]피리다진 0.3g이 얻어진다. 융점 285-287℃ 실시예 1에서 얻어진 표품과 혼융하면 융점 강하를 나타내지 않는다.20 ml of water was added, followed by extraction with chloroform, and the residue containing the extract was purified by column chromatography on silica gel (developing solution, benzene: acetone-1: 1) to obtain 7- (4-hydroxyphenyl) -1, 0.3 g of 4-dimorpholino pyrido [3,4-d] pyridazine is obtained. Melting point 285-287 ° C. Melting point of the product obtained in Example 1 does not show a melting point drop.

[실시예 6]Example 6

7-(4-벤질옥시페닐)-1, 4-비스-(2-메틸몰포리노)-피리도[3, 4-d]-피리다진 1.3g의 트리푸루오로초산 13ml 용액을 0.5시간 환류하에서 저어 섞는다. 감압하에 반응물을 농축하고, 잔류물에 벤젠 10ml을 가해서 농축한다. 잔류물을 메타놀 5ml에 녹여, 포화탄산수소나트륨 수용액을 가하면 황색결정이 석출한다. 이를 여취하고, 수세, 건조후, 초산에틸-메타놀 혼합액에서 재결정하면 융점 266-268℃의 황색침상정의 7-(4-히드록시페닐)-1, 4-비스-(2-메틸몰포리노)-피리도[3, 4-d]피리다진 0.6g이 얻어진다0.5 g of a 13 ml solution of 1.3 g of 7- (4-benzyloxyphenyl) -1, 4-bis- (2-methylmorpholino) -pyrido [3, 4-d] -pyridazine and 13 ml of trifuuroacetic acid was refluxed for 0.5 hour. Stir under. The reaction is concentrated under reduced pressure, and 10 ml of benzene is added to the residue. The residue is dissolved in 5 ml of methanol, and saturated aqueous sodium hydrogen carbonate is added to precipitate yellow crystals. This was filtered off, washed with water and dried, and then recrystallized from an ethyl acetate-methanol mixture to give 7- (4-hydroxyphenyl) -1, 4-bis- (2-methylmorpholino)-as a yellow needle at a melting point of 266-268 ° C. 0.6 g of pyrido [3,4-d] pyridazine is obtained

원소분석 C23H27O3N51/2H2O로 하여Elemental Analysis C 23 H 27 O 3 N 5 1 / 2H 2 O

이론값 C 64.63, H 6.56, N 16.27Theoretical C 64.63, H 6.56, N 16.27

실험값 C 65.11, H 6.33, N 16.11Experimental values C 65.11, H 6.33, N 16.11

[실시예 7]Example 7

7-(4-벤질옥시페닐)-1, 4-디피페리디노 피리도[3, 4-d]피리다진 1.2g의 트리푸루오로 초산 12ml용액을 0.5시간 환류하에서 저어 섞는다. 감압하에 반응물을 농축하고, 잔류물에 벤젠 10ml을 가하여 농축한다. 잔류물을 메타놀 5ml에 녹여, 포화탄산수소나트륨 수용액을 가하면 황색결정이 석출한다.Stir 1.2 g of 7- (4-benzyloxyphenyl) -1,4-dipiperidino pyrido [3,4-d] pyridazine in 12 ml of trifuuroacetic acid solution under reflux for 0.5 hour. The reaction is concentrated under reduced pressure, and 10 ml of benzene is added to the residue. The residue is dissolved in 5 ml of methanol, and saturated aqueous sodium hydrogen carbonate is added to precipitate yellow crystals.

이를 여취하고, 수세, 건조후, 초산 에틸-메타놀 혼합액에서 재결정하면 융점 300℃이상의 황색 분말결정으로서 7-(4-히드록시 페닐)-1, 4-디피페리디노 피리도[3, 4-d]피리다진 0.6g이 얻어진다.This was filtered off, washed with water and dried, and then recrystallized from an ethyl acetate-methanol mixture. As a yellow powder crystal having a melting point of 300 ° C. or higher, 7- (4-hydroxyphenyl) -1,4-dipiperidino pyrido [3,4-d ] 0.6 g of pyridazine is obtained.

원소분석 C23H27ON51/2H2O로 하여Elemental Analysis C 23 H 27 ON 5 1/2 H 2 O

이론값 C 69.82, H 7.08, N 17.57Theoretical C 69.82, H 7.08, N 17.57

실험값 C 70.52, H 6.96, N 17.18Experimental values C 70.52, H 6.96, N 17.18

[실시예 8]Example 8

7-(4-벤질옥시페닐)-8-메틸-1, 4-디몰포리노 피리도[3, 4-d]피리다진 2.0g의 트리푸루오로초산 20ml용액을 40분간 환류한다. 감압하에 트리푸루오로초산을 유거하고, 잔사에 벤젠 20ml을 가해서 농축건고한다. 잔류물을 탄산수소나트륨의 포화수액으로 중화한 후 클로로포름으로 추출한다. 추출액을 무수황산 나트륨으로 건조후 클로로포름을 유거해서 얻어진 조결정(粗結晶)을 에타놀에서 재결정하면, 황색침상정으로서 7-(4-히드록시페닐)-8-메틸-1, 4-디몰포리노피리도[3, 4-d]피리다진 1.2g이 얻어진다. 융점 264-266℃A 20 ml solution of 2.0 g of 7- (4-benzyloxyphenyl) -8-methyl-1, 4-dimorpholino pyrido [3, 4-d] pyridazine 2.0 g of trifururoacetic acid was refluxed for 40 minutes. Trifluuroacetic acid is distilled off under reduced pressure, 20 ml of benzene is added to the residue, and it is concentrated to dryness. The residue is neutralized with saturated saline solution of sodium hydrogen carbonate and then extracted with chloroform. After drying the extract with anhydrous sodium sulfate, the crude crystals obtained by distilling chloroform were recrystallized from ethanol to give 7- (4-hydroxyphenyl) -8-methyl-1,4-dimorpholino as yellow needles. 1.2 g of pyrido [3,4-d] pyridazine are obtained. Melting point 264-266 ℃

원소분석 C22H25O3N5로 하여Elemental Analysis C 22 H 25 O 3 N 5

이론값 C 64.85, H 6.18, N 17.19Theoretical C 64.85, H 6.18, N 17.19

실측값 C 64.74, H 6.14, N 17.05Found C 64.74, H 6.14, N 17.05

Claims (1)

본문에 상술한 바와같이 다음 일반식(I)로 표시되는 화합물과 환상아민을 반응시켜, R3이 저급알킬 또는 아랄킬기를 나타낼 경우에는, 다시 에에테르기의 개열(開裂)반응에 붙이는 일반식(Ⅱ)로 표시되는 피리도 [3, 4-d]피리다진류의 제조법As described above in the text, when the compound represented by the following general formula (I) is reacted with a cyclic amine, and R 3 represents a lower alkyl or aralkyl group, the general formula is added to the cleavage reaction of the ether group again. Manufacturing method of pyrido [3, 4-d] pyridazines represented by (II)
Figure kpo00012
Figure kpo00012
식중, R1은 수소원자 또는 메틸에틸기를.Wherein R 1 represents a hydrogen atom or a methylethyl group. X는 할로겐원자를,X is a halogen atom, R3은 수소원자, 저급알킬 또는 아랄킬기를,R 3 is a hydrogen atom, a lower alkyl or an aralkyl group, R2는 환상 아미노기를 나타냄.R 2 represents a cyclic amino group.
KR7500536A 1975-03-14 1975-03-14 Process for preparing pyrido(3,4-d)pyridazines KR790001082B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7500536A KR790001082B1 (en) 1975-03-14 1975-03-14 Process for preparing pyrido(3,4-d)pyridazines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7500536A KR790001082B1 (en) 1975-03-14 1975-03-14 Process for preparing pyrido(3,4-d)pyridazines

Publications (1)

Publication Number Publication Date
KR790001082B1 true KR790001082B1 (en) 1979-08-26

Family

ID=19201022

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7500536A KR790001082B1 (en) 1975-03-14 1975-03-14 Process for preparing pyrido(3,4-d)pyridazines

Country Status (1)

Country Link
KR (1) KR790001082B1 (en)

Similar Documents

Publication Publication Date Title
US3700673A (en) 3-4-dihydrobenzo(b) (1,7)naphthyridin-1(2h)-ones
Faber et al. Non‐steroidal antiinflammatory agents. 1. Synthesis of 4‐hydroxy‐2‐oxo‐1, 2‐dihydroquinolin‐3‐yl alkanoic acids by the wittig reaction of quinisatines
KR930004652B1 (en) Process for the quinolone carboxylic acid
HU215429B (en) Process for producing ((6,7-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolin-carboxylic acid)-0 upper 3, 0 upper 4-bis(acyl-oxy)-borate and salts
JPH0477B2 (en)
KR790001082B1 (en) Process for preparing pyrido(3,4-d)pyridazines
JPS5811874B2 (en) Pyrido (3,4-D) Pyridazine Luino Seizouhou
US4894457A (en) 7-bromo-beta-carboline compound and method for producing same
EP0238411A1 (en) 1,2-Dihydro-4-methyl-1-oxo-5H-pyrido(4,3-b) indoles and their preparation
US4017490A (en) Pyrido (3,4-d)pyridazines
KR870001625B1 (en) Process for preparing n-pyrrolyl pyridazineamines derivatives
KR940009792B1 (en) Process for preparing benzoxazine carboxylic acid derivatives
US3426026A (en) Preparation of phenanthrolines
KR790001072B1 (en) Process for preparing pyrido(3,4-d)pyridazines
KR100249637B1 (en) Derivatives of fluoro-quinoline carboxylic-3-acid and preparation therefor
JPH04169583A (en) Phenothiazine derivative and its production
EP0026675B1 (en) 1-azaxanthone-3-carboxylic acids, their preparation and pharmaceutical compositions containing them
JPH05140157A (en) Phenothiazine derivative
US6583298B1 (en) Process for the synthesis of 17β-hydroxy-17α-methyl-2-oxa-5α-androstane-3-one
US2589223A (en) Hydroxy-tetrahydro-naphthoyl-alkanoic acids
KR800000736B1 (en) Process for preparing 4-oxo-1,2,3,4-tetra hydropyrido(2,3-d)pyrimidin derivatives
US4132851A (en) Process for producing quinazolone derivatives
PL171318B1 (en) Method of obtaining benzo[b]naphtyridines
US3311632A (en) 3-acetyl-cinchoninic acid compounds
US6465653B2 (en) Noncatalyzed synthesis of 4-hydroxyquinolines and/or tautomers thereof